Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 218067
Company: QILU ANTIBIOTICS
Company: QILU ANTIBIOTICS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ERTAPENEM SODIUM | ERTAPENEM SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 10/31/2024 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
ERTAPENEM SODIUM
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS; EQ 1GM BASE/VIAL
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| ERTAPENEM SODIUM | ERTAPENEM SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Prescription | No | AP | 208790 | ACS DOBFAR SPA |
| ERTAPENEM SODIUM | ERTAPENEM SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Prescription | No | AP | 209133 | EUGIA PHARMA |
| ERTAPENEM SODIUM | ERTAPENEM SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Prescription | No | AP | 212040 | GLAND |
| ERTAPENEM SODIUM | ERTAPENEM SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Prescription | No | AP | 218067 | QILU ANTIBIOTICS |
| ERTAPENEM SODIUM | ERTAPENEM SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Prescription | No | AP | 207647 | SAVIOR LIFETEC CORP |
| INVANZ | ERTAPENEM SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Prescription | Yes | AP | 021337 | MSD SUB MERCK |